425: Strive Details Semler Scientific All-Stock Merger

Strive, Inc. filed an 8-K providing pro forma financials and risk factors for its pending all-stock acquisition of Semler Scientific, Inc.

Summary

• Strive, Inc. (ASST) is acquiring Semler Scientific, Inc. (SMLR) in an all-stock merger, with the Merger Agreement signed on September 22, 2025.
• Both Strive's and Semler Scientific's boards of directors unanimously approved the Merger Agreement on September 21, 2025.
• Each share of Semler Scientific common stock will be converted into the right to receive 21.05 shares of Strive Class A common stock.
• Strive is deemed the accounting acquirer, with its existing stockholders expected to hold the greatest voting interest and its senior management controlling the combined entity's strategic direction.
• The filing includes historical financial statements for Semler Scientific and unaudited pro forma combined consolidated financial information for Strive and Semler Scientific.
• Pro forma financials give effect to the merger as if completed on January 1, 2024, for the statement of operations, and June 30, 2025, for the balance sheet.
• The pro forma combined entity's total assets are estimated at $2,463,466,465 as of June 30, 2025, including $1,171,865,000 in intangible digital assets and $1,196,763,113 in goodwill.
• The pro forma combined entity reported a net loss of $(17,386,666) for the six months ended June 30, 2025, and $(12,851,934) for the year ended December 31, 2024.
• The estimated purchase price consideration for Semler Scientific is $1,441,536,300, based on 335,241,000 shares of Strive Class A common stock issued at $4.30 per share.

Sentiment

Score: 4

Explanation: The filing details a significant strategic merger, which is generally positive for growth. However, the pro forma financials indicate net losses for the combined entity, and the extensive list of merger-related risks, including integration challenges, potential dilution, and the possibility of the merger not closing, introduce considerable uncertainty and downside potential. The 'Bitcoin Treasury Company' aspect also implies higher volatility.

Positives

• The merger is anticipated to yield strategic and financial benefits, including positive impacts on the combined company's future financial performance.
• The boards of directors of both Strive and Semler Scientific unanimously approved the merger, indicating strong internal support for the transaction.

Negatives

• The unaudited pro forma combined consolidated financial statements project a net loss of $(17,386,666) for the six months ended June 30, 2025, and $(12,851,934) for the year ended December 31, 2024.
• The pro forma net loss per share for the combined entity is projected at $(0.01) for both the six months ended June 30, 2025, and the year ended December 31, 2024.

Risks

• The merger is subject to various closing conditions, including Semler Scientific stockholder approval and antitrust clearance, which may not be satisfied or could be delayed.
• Governmental or regulatory agencies could seek to block or challenge the merger or impose restrictions as conditions for approval, potentially affecting the combined company.
• Failure to complete the merger or significant delays could negatively affect the trading prices of Strive and Semler Scientific common stock and their future business and financial results.
• The Merger Agreement contains provisions that limit Strive's and Semler Scientific's ability to pursue alternative transactions and could discourage competing proposals.
• Strive and Semler Scientific are subject to contractual restrictions on business operations between the agreement date and closing, potentially preventing beneficial changes or opportunities.
• The merger process may distract management teams from ongoing responsibilities, affecting business operations and earnings before closing.
• Uncertainty regarding the merger may cause third parties (e.g., customers) to delay or defer decisions, or seek to change/cancel existing business relationships.
• The merger may negatively impact Strive's and Semler Scientific's ability to attract and retain key personnel due to uncertainty about future roles.
• Market prices of Strive and Semler Scientific common stock may fluctuate significantly during the pendency of the merger and after completion.
• Strive is subject to contractual restrictions that may hinder its operations, and Semler Scientific's corollary restrictions may not prevent actions adverse to Strive.
• Significant non-recurring transaction costs will be incurred by both companies, which may not be offset by anticipated benefits in the near term or at all.
• The unaudited pro forma financial information is illustrative and may not be representative of the combined company's actual financial position or results of operations.
• The merger may not be accretive to Strive's or Semler Scientific's earnings per share and could cause dilution, potentially affecting stock prices.
• Stockholder litigation could prevent or delay the closing or negatively impact businesses and operations.
• Future sales and issuance of Strive Class A Common Stock could result in dilution of percentage ownership and cause stock prices to fall.
• Failure to successfully combine the businesses of Strive and Semler Scientific in the expected timeframe or at all may adversely affect the future results of the combined company.
• The market price of Strive Class A Common Stock after the merger may be affected by factors different from those historically affecting Strive.
• Each company may have unknown or contingent liabilities that could adversely affect the combined company's financial condition and results of operations.
• There is no guarantee that the combined company will declare and pay dividends following the merger.
• Future disclosures relating to the merger, including detailed background and prospective financial information, may not align with investor expectations and could impact Strive's stock price.

Future Outlook

Strive anticipates the merger with Semler Scientific will be accretive to its forecasted earnings per share on a standalone basis, beginning in the first full calendar year after closing. However, these expectations are based on preliminary estimates and are subject to various risks and uncertainties, including integration challenges and potential additional costs. The pro forma financial information does not purport to project the future financial position or operating results of the combined company.

Industry Context

Strive, Inc. operates as an asset management Bitcoin Treasury Company, generating income from bitcoin investments and investment advisory services. The acquisition of Semler Scientific, a company whose common stock also trades on Nasdaq, suggests a strategic move to expand or diversify Strive's asset base or operational scope, potentially integrating Semler's business into Strive's broader investment or operational strategy. The significant allocation of PIPE financing proceeds to bitcoin purchases highlights Strive's continued focus on digital assets within its asset management framework.

Corporate Governance

Stakeholder Impact

• Shareholders of Semler Scientific will become shareholders of Strive, subject to the combined company's performance and risks.
• Shareholders of Strive may experience dilution due to the issuance of additional shares for the acquisition.
• Employees of both companies may experience uncertainty regarding their future roles, potentially impacting retention and motivation.
• Customers of both companies may delay or defer decisions or seek to change existing business relationships due to merger uncertainty.
• The combined company's financial performance and stock price will impact investors, potentially affecting their investment value.

Next Steps

• Semler Scientific stockholders must approve and adopt the Merger Agreement.
• Strive and Semler Scientific must obtain antitrust clearance from governmental authorities (e.g., HSR Act expiration/termination).
• Strive intends to file a Registration Statement on Form S-4, which will include an information statement, proxy statement, and prospectus, with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval.
• The companies will work towards satisfying all customary closing conditions outlined in the Merger Agreement.

Key Dates

Recommendation

The filing details a significant all-stock merger that could offer strategic benefits, but the pro forma financials indicate projected net losses for the combined entity. The extensive list of risks, including integration challenges, potential dilution, regulatory hurdles, and the possibility of the merger not closing, introduces substantial uncertainty. While the 'Bitcoin Treasury Company' aspect of Strive could offer growth potential, it also adds volatility. A seasoned investor would likely 'hold' to observe the successful completion of the merger, the integration process, and the actual financial performance of the combined entity before making a more definitive investment decision.

Keywords

Strive Inc, Semler Scientific, Merger, Acquisition, All-stock transaction, SEC filing, 8-K, Pro forma financials, Risk factors, Bitcoin Treasury Company, Asset management, Corporate governance, Nasdaq